DEVS vs GILD
DevvStream Corp. Common Stock (DEVS) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
DEVS currently screens at market cap $13.4M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the DEVS and GILD stock pages for the full models.
Not investment advice.